Litigation and opioid-related claims
The company has recorded charges for estimated opioid-related liabilities and continues to face legal disputes.
- Scope
- Claims, settlements and legal defense costs
- Materiality
- high
McKesson Corporation
McKesson Corp is a healthcare distribution and services company that moves branded, generic, specialty, biosimilar, and OTC medicines through large-scale pharmaceutical logistics networks. It also provides medical-surgical supply distribution, pharmacy technology, specialty health services, and market-access support, with major operations in the United States and Canada.
1,6 %
3,6 %
1,2 %
+12,4 %
0.85
0.49
| % | |
|---|---|
| U.S. Pharmaceutical Distribution | 78% Distribution and logistics for prescription drugs and related healthcare products across retail, institutional and specialty channels. |
| Medical-Surgical Solutions | 10% Medical-supply distribution, logistics, biomedical maintenance and support services for alternate-site providers. |
| International | 9% Pharmaceutical wholesale, retail pharmacy, specialty health services and market-access solutions in Canada and Norway. |
| Prescription Technology Solutions | 3% Technology-enabled pharmacy workflow, inventory, ordering and automation solutions for pharmacy customers. |
McKesson sells primarily to pharmacies, hospitals, health systems, long-term care providers, oncology and other...
- Retail national accountsprimary
National and regional chains, mail-order pharmacies and mass merchandisers buy high-volume pharmaceutical distribution, central fill and inventory solutions to improve replenishment speed and cost efficiency.
- Community pharmaciesprimary
Independent and small-to-medium chain pharmacies buy generics, ordering systems, inventory tools and merchandising programs to improve cash flow and profitability.
- Institutional healthcare providersprimary
Hospitals, health systems, integrated delivery networks and long-term care providers buy pharmaceuticals and medical-surgical supplies to support patient care operations.
- Specialty and oncology practicessecondary
Oncology, specialty and biopharma-related practices buy specialty drug distribution, patient support and logistics services for complex therapies.
- Pharmaceutical manufacturers and biopharma partnerssecondary
Manufacturers use McKesson for distribution, logistics, market access and specialty services to reach providers and patients efficiently.
McKesson is heavily concentrated in the United States, where its pharmaceutical and medical-surgical networks operate...
- •United States is the core market for pharmaceutical and medical-surgical distribution
- •Canada is the main international market and includes wholesale, retail and specialty services
- •Norway is the remaining European operating market after broader Europe exits
- •U.S. distribution runs through 27 distribution centers and two redistribution centers
- •Canada includes a national distribution network and pharmacy banner footprint
McKesson is focused on scaling its core pharmaceutical distribution franchise, expanding specialty and biopharma...
01
Grow specialty and biopharma servicesmedium-term
Specialty therapies are higher-touch and can deepen customer relationships beyond commodity distribution.
02
Improve operating efficiency through automationshort-term
Distribution is a low-margin business, so automation and process discipline protect service levels and margins.
03
Portfolio simplification and separationmedium-term
Separating non-core assets can improve strategic focus and capital allocation.
McKesson faces litigation, regulatory and reimbursement risk because it operates in highly regulated drug distribution...
Cybersecurity incidents
McKesson handles protected health information and critical logistics systems that are attractive targets for cyberattacks.
- Scope
- Data breach, operational disruption and regulatory action
- Materiality
- high
Regulatory and pricing pressure
Drug distribution and pharmacy services are exposed to healthcare regulation, reimbursement changes and government actions.
- Scope
- Margins, customer economics and compliance costs
- Materiality
- high
Goodwill and long-lived asset impairment
Acquisitions and portfolio changes require judgment on future cash flows and fair values.
- Scope
- Reporting units, intangibles and acquired businesses
- Materiality
- medium
Contingent liabilities for opioid-related claims
Can create large, non-recurring expense and liability swings
LIFO inventory accounting
Can move gross margin up or down with drug price inflation
Goodwill impairment testing
Potential non-cash write-downs in future periods
Restructuring and divestiture accounting
Affects operating profit and period-to-period comparability
: 11/08/2026